{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T08:10:18Z","timestamp":1770711018141,"version":"3.49.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T00:00:00Z","timestamp":1706140800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["LCF\/PR\/HP17\/52190002"],"award-info":[{"award-number":["LCF\/PR\/HP17\/52190002"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["PTDC\/DTP-PIC\/4104\/2014"],"award-info":[{"award-number":["PTDC\/DTP-PIC\/4104\/2014"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["SFRH\/BD\/145216\/2019"],"award-info":[{"award-number":["SFRH\/BD\/145216\/2019"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.ejphar.2024.176336","type":"journal-article","created":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T02:19:07Z","timestamp":1705976347000},"page":"176336","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Acute and chronic effects of levosimendan in the ZSF1 obese rat model of heart failure with preserved ejection fraction"],"prefix":"10.1016","volume":"966","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5096-3660","authenticated-orcid":false,"given":"Liliana","family":"Moreira-Costa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Tavares-Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u00e3o","family":"Almeida-Coelho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5386-8378","authenticated-orcid":false,"given":"Alexandre","family":"Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3415-2040","authenticated-orcid":false,"given":"F\u00e1bio","family":"Trindade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Vasques-N\u00f3voa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cl\u00e1udia","family":"Sousa-Mendes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Leite","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Vitorino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"In\u00eas","family":"Falc\u00e3o-Pires","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adelino F.","family":"Leite-Moreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5756-9535","authenticated-orcid":false,"given":"Andr\u00e9 P.","family":"Louren\u00e7o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2024.176336_bib1","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s00210-022-02348-7","article-title":"Levosimendan increases the phosphorylation state of phospholamban in the isolated human atrium","volume":"396","author":"Abella","year":"2023","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"10.1016\/j.ejphar.2024.176336_bib2","doi-asserted-by":"crossref","first-page":"491","DOI":"10.17235\/reed.2017.4575\/2016","article-title":"Characterization of liver changes in ZSF1 rats, an animal model of metabolic syndrome","volume":"109","author":"Borges Canha","year":"2017","journal-title":"Rev. Esp. Enferm. Dig."},{"key":"10.1016\/j.ejphar.2024.176336_bib3","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.jacc.2010.03.077","article-title":"Global cardiovascular reserve dysfunction in heart failure with preserved ejection fraction","volume":"56","author":"Borlaug","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejphar.2024.176336_bib4","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1016\/j.jacc.2023.01.049","article-title":"Heart failure with preserved ejection fraction: JACC scientific statement","volume":"81","author":"Borlaug","year":"2023","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejphar.2024.176336_bib5","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.jchf.2021.01.015","article-title":"Levosimendan improves hemodynamics and exercise tolerance in PH-HFpEF: results of the randomized placebo-controlled HELP trial","volume":"9","author":"Burkhoff","year":"2021","journal-title":"JACC. Heart failure"},{"key":"10.1016\/j.ejphar.2024.176336_bib6","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1161\/CIRCULATIONAHA.121.057812","article-title":"Empagliflozin, Health status, and quality of life in patients with heart failure and preserved ejection fraction: the EMPEROR-preserved trial","volume":"145","author":"Butler","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2024.176336_bib7","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1161\/01.RES.77.1.107","article-title":"Effects of Levosimendan, a cardiotonic agent targeted to troponin C, on cardiac function and on phosphorylation and Ca2+ sensitivity of cardiac myofibrils and sarcoplasmic reticulum in Guinea pig heart","volume":"77","author":"Edes","year":"1995","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2024.176336_bib8","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/s41380-022-01806-1","article-title":"Molecular pathways of major depressive disorder converge on the synapse","volume":"28","author":"Fries","year":"2023","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.ejphar.2024.176336_bib9","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.jacc.2020.11.044","article-title":"Etiology-dependent impairment of diastolic cardiomyocyte calcium homeostasis in heart failure with preserved ejection fraction","volume":"77","author":"Frisk","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejphar.2024.176336_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20092164","article-title":"ERK: a key player in the pathophysiology of cardiac hypertrophy","volume":"20","author":"Gallo","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2024.176336_bib11","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.118.005622","article-title":"Endothelial leptin receptor deletion promotes cardiac autophagy and angiogenesis following pressure overload by suppressing akt\/mTOR signaling","volume":"12","author":"Gogiraju","year":"2019","journal-title":"Circ. Heart Fail"},{"key":"10.1016\/j.ejphar.2024.176336_bib12","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/978-1-4939-8597-5_7","article-title":"Measuring cardiomyocyte contractility and calcium handling in vitro","volume":"1816","author":"Gorski","year":"2018","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ejphar.2024.176336_bib13","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/ehf2.13142","article-title":"Muscular changes in animal models of heart failure with preserved ejection fraction: what comes closest to the patient?","volume":"8","author":"Goto","year":"2021","journal-title":"ESC heart failure"},{"key":"10.1016\/j.ejphar.2024.176336_bib14","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1161\/CIRCHEARTFAILURE.113.000539","article-title":"Myocardial titin hypophosphorylation importantly contributes to heart failure with preserved ejection fraction in a rat metabolic risk model","volume":"6","author":"Hamdani","year":"2013","journal-title":"Circulation. Heart failure"},{"key":"10.1016\/j.ejphar.2024.176336_bib15","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1161\/01.CIR.98.20.2141","article-title":"Influence of the novel inotropic agent levosimendan on isometric tension and calcium cycling in failing human myocardium","volume":"98","author":"Hasenfuss","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2024.176336_bib16","first-page":"e876","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: executive summary: a report of the American college of cardiology\/American heart association joint committee on clinical practice guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2024.176336_bib17","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.ijcard.2012.11.035","article-title":"Impaired left ventricular systolic function reserve limits cardiac output and exercise capacity in HFpEF patients due to systemic hypertension","volume":"168","author":"Henein","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ejphar.2024.176336_bib18","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ejphar.2017.09.014","article-title":"KATP channel block inhibits the Toll-like receptor 2-mediated stimulation of NF-\u03baB by suppressing the activation of Akt, mTOR, JNK and p38-MAPK","volume":"815","author":"Jeong Nam","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2024.176336_bib19","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.jacc.2013.09.052","article-title":"Impaired systolic function by strain imaging in heart failure with preserved ejection fraction","volume":"63","author":"Kraigher-Krainer","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejphar.2024.176336_bib20","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.118.005596","article-title":"Arterial remodeling and dysfunction in the ZSF1 rat model of heart failure with preserved ejection fraction","volume":"12","author":"Leite","year":"2019","journal-title":"Circulation. Heart failure"},{"key":"10.1016\/j.ejphar.2024.176336_bib21","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1177\/10742484211034253","article-title":"Chronic sildenafil therapy in the ZSF1 obese rat model of metabolic syndrome and heart failure with preserved ejection fraction","volume":"26","author":"Leite","year":"2021","journal-title":"J. Cardiovasc. Pharmacol. Therapeut."},{"key":"10.1016\/j.ejphar.2024.176336_bib22","doi-asserted-by":"crossref","first-page":"H1556","DOI":"10.1152\/ajpheart.00076.2015","article-title":"Echocardiography and invasive hemodynamics during stress testing for diagnosis of heart failure with preserved ejection fraction: an experimental study","volume":"308","author":"Leite","year":"2015","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ejphar.2024.176336_bib23","doi-asserted-by":"crossref","first-page":"H1648","DOI":"10.1152\/ajpheart.00397.2015","article-title":"Afterload-induced diastolic dysfunction contributes to high filling pressures in experimental heart failure with preserved ejection fraction","volume":"309","author":"Leite","year":"2015","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ejphar.2024.176336_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1009646","article-title":"In silico identification of potential calcium dynamics and sarcomere targets for recovering left ventricular function in rat heart failure with preserved ejection fraction","volume":"17","author":"Longobardi","year":"2021","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.ejphar.2024.176336_bib25","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/ejhf.1059","article-title":"An integrative translational approach to study heart failure with preserved ejection fraction: a position paper from the Working Group on Myocardial Function of the European Society of Cardiology","volume":"20","author":"Lourenco","year":"2018","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ejphar.2024.176336_bib26","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/FJC.0000000000000859","article-title":"Levosimendan efficacy and safety: 20 Years of SIMDAX in clinical use","volume":"76","author":"Papp","year":"2020","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ejphar.2024.176336_bib27","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jtcvs.2011.09.020","article-title":"Levosimendan is superior to epinephrine in improving myocardial function after cardiopulmonary bypass with deep hypothermic circulatory arrest in rats","volume":"143","author":"Rungatscher","year":"2012","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.ejphar.2024.176336_bib28","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1161\/CIRCRESAHA.117.311147","article-title":"New insights into the role of mTOR signaling in the cardiovascular system","volume":"122","author":"Sciarretta","year":"2018","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2024.176336_bib29","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ejphar.2010.12.035","article-title":"Levosimendan preserves the contractile responsiveness of hypoxic human myocardium via mitochondrial K(ATP) channel and potential pERK 1\/2 activation","volume":"655","author":"Soeding","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2024.176336_bib30","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.yjmcc.2020.05.008","article-title":"A directed network analysis of the cardiome identifies molecular pathways contributing to the development of HFpEF","volume":"144","author":"Summer","year":"2020","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.ejphar.2024.176336_bib31","doi-asserted-by":"crossref","first-page":"H914","DOI":"10.1152\/ajpheart.00465.2004","article-title":"Levosimendan improves LV systolic and diastolic performance at rest and during exercise after heart failure","volume":"288","author":"Tachibana","year":"2005","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ejphar.2024.176336_bib32","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1210\/en.2003-1128","article-title":"Leptin increases cardiomyocyte hyperplasia via extracellular signal-regulated kinase- and phosphatidylinositol 3-kinase-dependent signaling pathways","volume":"145","author":"Tajmir","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejphar.2024.176336_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.677727","article-title":"A porcine model of heart failure with preserved ejection fraction induced by chronic pressure overload characterized by cardiac fibrosis and remodeling","volume":"8","author":"Tan","year":"2021","journal-title":"Frontiers in Cardiovascular Medicine"},{"key":"10.1016\/j.ejphar.2024.176336_bib34","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1177\/1074248417696818","article-title":"Dose-response head-to-head comparison of inodilators dobutamine, milrinone, and levosimendan in chronic experimental pulmonary hypertension","volume":"22","author":"Tavares-Silva","year":"2017","journal-title":"J. Cardiovasc. Pharmacol. Therapeut."},{"key":"10.1016\/j.ejphar.2024.176336_bib35","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1002\/ehf2.13168","article-title":"Comparison of levosimendan, NO, and inhaled iloprost for pulmonary hypertension reversibility assessment in heart transplant candidates","volume":"8","author":"Tavares-Silva","year":"2021","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.ejphar.2024.176336_bib36","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1081\/JDI-100100882","article-title":"Renal function and structure in diabetic, hypertensive, obese ZDFxSHHF-hybrid rats","volume":"22","author":"Tofovic","year":"2000","journal-title":"Ren. Fail."},{"key":"10.1016\/j.ejphar.2024.176336_bib37","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/j.1476-5381.2010.01048.x","article-title":"Levosimendan improves calcium sensitivity of diaphragm muscle fibres from a rat model of heart failure","volume":"162","author":"van Hees","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2024.176336_bib38","article-title":"Exercise capacity is improved by levosimendan in heart failure and sarcopenia via alleviation of apoptosis of skeletal muscle","volume":"12","author":"Wang","year":"2021","journal-title":"Front. Physiol."},{"key":"10.1016\/j.ejphar.2024.176336_bib39","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s11010-011-0744-2","article-title":"mTOR mediates RhoA-dependent leptin-induced cardiomyocyte hypertrophy","volume":"352","author":"Zeidan","year":"2011","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.ejphar.2024.176336_bib40","series-title":"Levosimendan Reverses Cardiac Malfunction and Cardiomyocyte Ferroptosis during Heart Failure with Preserved Ejection Fraction via Connexin 43 Signaling Activation","author":"Zhang","year":"2023"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299924000244?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299924000244?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T04:27:08Z","timestamp":1762144028000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299924000244"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":40,"alternative-id":["S0014299924000244"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2024.176336","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acute and chronic effects of levosimendan in the ZSF1 obese rat model of heart failure with preserved ejection fraction","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2024.176336","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"176336"}}